A hypothesis for the pathogenesis of radiation-induced oral mucositis: when biological challenges exceed physiologic protective mechanisms. Implications for pharmacological prevention and treatment
- PMID: 33712912
- PMCID: PMC8295245
- DOI: 10.1007/s00520-021-06108-w
A hypothesis for the pathogenesis of radiation-induced oral mucositis: when biological challenges exceed physiologic protective mechanisms. Implications for pharmacological prevention and treatment
Abstract
Oral mucositis (OM) remains a significant unmet need for patients being treated with standard concomitant chemoradiation (CRT) regimens for head and neck cancers (HNC). OM's pathogenesis is complex and includes both direct and indirect damage pathways. In this paper, the field is reviewed with emphasis on the initiating and sustaining role of oxidative stress on OM's pathobiology. A hypothesis is presented which suggests that based on OM's clinical and biological trajectory, mucosal damage is largely the consequence of cumulative CRT-induced biological changes overwhelming physiologic self-protective mechanisms. Furthermore, an individual's ability to mount and maintain a protective response is dependent on interacting pathways which are primarily determined by a multiplex consisting of genomics, epigenomics, and microbiomics. Effective biologic or pharmacologic OM interventions are likely to supplement or stimulate existing physiologic damage-control mechanisms.
Keywords: Mucositis; Oxidative stress; Pathobiology; Radiation.
© 2021. The Author(s).
Conflict of interest statement
Dr. Sonis reports personal fees from Biomodels, LLC, personal fees from Primary Endpoint Solutions, LLC (PES), outside of the submitted work. As an employee of Biomodels and PES, he is involved in assisting industry, government and academics in the study, and enablement of drugs, biologicals, and devices to treat patients for a broad range of indications including cancer and oral toxicities of cancer therapy. He does not have equity or receive payment from any of the companies’ clients. This review was funded in part by a grant to PES from Galera Therapeutics which is among the companies developing a mucositis intervention based on mitigating radiation-induced oxidative stress.
Figures



References
-
- Lalla RV et al (2019) Oral mucositis due to high-dose chemotherapy and/or head and neck radiation therapy. J Natl Cancer Inst Monogr 2019(53):Igz011 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials